Virologic and Immunologic Characterization of Coronavirus Disease 2019 Recrudescence After Nirmatrelvir/Ritonavir Treatment

被引：42
|
作者：
Carlin, Aaron F. [1 ]
Clark, Alex E. [1 ]
Chaillon, Antoine [1 ]
Garretson, Aaron F. [1 ]
Bray, William [2 ]
Porrachia, Magali [1 ]
Santos, AsherLev T. [3 ]
Rana, Tariq M. [4 ]
Smith, Davey M. [1 ,5 ]
机构：
[1] Univ Calif San Diego, Sch Med, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA
[3] Calif State Univ San Marcos, Coll Educ Hlth & Human Serv, Dept Publ Hlth, San Marcos, CA USA
[4] Univ Calif San Diego, UCSD Ctr AIDS Res, Inst Genom Med, Dept Pediat Program Immunol,Div Genet, La Jolla, CA 92093 USA
[5] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA
来源：
CLINICAL INFECTIOUS DISEASES | 2023年 / 76卷 / 03期
关键词：
COVID-19; treatment rebound; recrudescence; nirmatrelvir; Omicron;
D O I：
10.1093/cid/ciac496
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We isolated a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BA.2 variant from a person with coronavirus disease 2019 recrudescence after nirmatrelvir/ritonavir treatment. Antiviral sensitivity and neutralizing antibody testing were performed with both parental SARS-CoV-2 and multiple variants of concern. We found that neither nirmatrelvir resistance nor absence of neutralizing immunity was a likely cause of the recrudescence.
引用
收藏
页码：E530 / E532
页数：3
相关论文
共 50 条
  • [21] Clinical outcomes of nirmatrelvir-ritonavir use in pregnant women during the Omicron wave of the coronavirus disease 2019 pandemic
    Lin, Chih-Wei
    Liang, Yu-Ling
    Chuang, Ming-Ta
    Tseng, Chun-Han
    Tsai, Pei-Yin
    Su, Mei-Tsz
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (12) : 1942 - 1946
  • [22] Oral Nirmatrelvir-Ritonavir Use and Clinical Outcomes in Pregnant Patients With Coronavirus Disease 2019 (COVID-19)
    Toure, Bineta B.
    Panakam, Aisvarya
    Johns, Sarah L.
    Butler, Sharlay K.
    Tuomala, Ruth E.
    Diouf, Khady
    OBSTETRICS AND GYNECOLOGY, 2024, 143 (02): : 273 - 276
  • [23] Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019
    Yamamoto, Chie
    Taniguchi, Masashi
    Furukawa, Keitaro
    Inaba, Toru
    Niiyama, Yui
    Ide, Daisuke
    Mizutani, Shinsuke
    Kuroda, Junya
    Tanino, Yoko
    Nishioka, Keisuke
    Watanabe, Yohei
    Takayama, Koichi
    Nakaya, Takaaki
    Nukui, Yoko
    VIRUSES-BASEL, 2024, 16 (05):
  • [24] Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019
    Yu, Miao
    Wang, Deng-Chao
    Li, Sheng
    Lei, Yue-Hua
    Wei, Jian
    Huang, Li-Yan
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1513 - 1522
  • [25] Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19
    Camp, Daniel
    Caputo, Matthew
    Echevarria, Fabiola Moreno
    Achenbach, Chad J.
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [26] Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)
    Chang, Feng-Yee
    Chen, Hsiang-Cheng
    Chen, Pei-Jer
    Ho, Mei-Shang
    Hsieh, Shie-Liang
    Lin, Jung-Chung
    Liu, Fu-Tong
    Sytwu, Huey-Kang
    JOURNAL OF BIOMEDICAL SCIENCE, 2020, 27 (01)
  • [27] Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
    Wong, Grace Lai-Hung
    Yip, Terry Cheuk-Fung
    Lai, Mandy Sze-Man
    Wong, Vincent Wai-Sun
    Hui, David Shu-Cheong
    Lui, Grace Chung-Yan
    JAMA NETWORK OPEN, 2022, 5 (12) : e2245086
  • [28] Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)
    Feng-Yee Chang
    Hsiang-Cheng Chen
    Pei-Jer Chen
    Mei-Shang Ho
    Shie-Liang Hsieh
    Jung-Chung Lin
    Fu-Tong Liu
    Huey-Kang Sytwu
    Journal of Biomedical Science, 27
  • [29] Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report
    Almarhabi, Hassan
    Alharbi, Aisha
    Alalawi, Mai
    Ahamed, Mohamed Firoze
    El-Hemaidi, Ihab
    Damfu, Nader
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2024, 17 (10)
  • [30] Clinical efficacy of methylprednisolone and the combined use of lopinavir/ritonavir with arbidol in treatment of coronavirus disease 2019
    Xia, Qi
    Dai, Wanrong
    Xu, Kaijin
    Ni, Qin
    Li, Yongtao
    Liu, Jun
    Zhao, Hong
    Guo, Yongzheng
    Yu, Liang
    Yi, Ping
    Su, Junwei
    Lang, Guanjing
    Tao, Jingjing
    Shi, Ding
    Wu, Wenrui
    Wu, Xiaoxin
    Xu, Yan
    Xu, Min
    Yu, Ling
    Wang, Xiaoyan
    Cai, Hongliu
    Fang, Qiang
    Zhou, Jianying
    Qiu, Yunqing
    Li, Lanjuan
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4446 - 4453
12345